BioSenic S.A. Cash Flow Conversion Efficiency

Latest as of December 2024: 0.052x

BioSenic S.A. cash flow conversion efficiency. Based on the latest financial reports, BioSenic S.A. (BIOS) has a cash flow conversion efficiency ratio of 0.052x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.39 Million ≈ $-1.62 Million USD) by net assets (€-26.81 Million ≈ $-31.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of BioSenic S.A. (2012–2024)

Cash flow conversion efficiency of BioSenic S.A. from 2012 to 2024. This chart illustrates how BioSenic S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View BIOS share price today for real-time trading data and today's change.

BioSenic S.A. Cash Flow Conversion Ratio Explained

BioSenic S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BioSenic S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioSenic S.A. ranked by their cash flow conversion efficiency. Also see market cap of BioSenic S.A. for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Elevai Labs, Inc. Common Stock NASDAQ:ELAB	-0.119x
Triangle Energy (Global) Ltd AU:TEG	3.581x
Lazydays Holdings Inc NASDAQ:GORV	0.889x
BrightBid Group AB (publ) ST:PERP-B	-0.071x
CQS Natural Resources Growth and Income plc LSE:CYN	0.014x
TNL Mediagene Ordinary Shares NASDAQ:TNMG	-3.332x
Avrupa Minerals Ltd V:AVU	-0.155x
Shirpur Gold Refinery Limited NSE:SHIRPUR-G	-0.008x

Annual Cash Flow Conversion Efficiency for BioSenic S.A. (2012–2024)

The table below shows the annual cash flow conversion efficiency of BioSenic S.A. from 2012 to 2024. Review BioSenic S.A. free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-26.81 Million ≈ $-31.34 Million	€-2.23 Million ≈ $-2.61 Million	0.083x	-45.50%
2023-12-31	€-22.70 Million ≈ $-26.54 Million	€-3.47 Million ≈ $-4.06 Million	0.153x	+125.00%
2022-12-31	€3.12 Million ≈ $3.65 Million	€-1.91 Million ≈ $-2.23 Million	-0.611x	-132.35%
2021-12-31	€-6.76 Million ≈ $-7.91 Million	€-12.78 Million ≈ $-14.95 Million	1.890x	+139.07%
2020-12-31	€3.33 Million ≈ $3.89 Million	€-16.08 Million ≈ $-18.80 Million	-4.837x	+4.75%
2019-12-31	€2.05 Million ≈ $2.39 Million	€-10.40 Million ≈ $-12.16 Million	-5.078x	-76.78%
2018-12-31	€4.49 Million ≈ $5.25 Million	€-12.90 Million ≈ $-15.08 Million	-2.873x	+37.87%
2017-12-31	€2.38 Million ≈ $2.79 Million	€-11.02 Million ≈ $-12.88 Million	-4.624x	-521.01%
2016-12-31	€15.27 Million ≈ $17.85 Million	€-11.37 Million ≈ $-13.29 Million	-0.745x	-78.12%
2015-12-31	€28.15 Million ≈ $32.91 Million	€-11.77 Million ≈ $-13.75 Million	-0.418x	-212.50%
2014-12-31	€-9.48 Million ≈ $-11.09 Million	€-3.52 Million ≈ $-4.12 Million	0.372x	+100.71%
2013-12-31	€63.00K ≈ $73.65K	€-3.27 Million ≈ $-3.83 Million	-51.968x	-3284.99%
2012-12-31	€2.64 Million ≈ $3.08 Million	€-4.05 Million ≈ $-4.73 Million	-1.535x	--

About BioSenic S.A.

BR:BIOS Belgium Biotechnology

Market Cap

$1.68 Million

€1.44 Million EUR

Market Cap Rank

#30285 Global

#110 in Belgium

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.00

All Time High

€20.66